US Stock MarketDetailed Quotes

ANIK Anika Therapeutics

Watchlist

25.630
+0.370+1.46%

Close May 10 16:00 ET

25.630
0.0000.00%

Post 16:00 ET

380.05MMarket Cap-4891P/E (TTM)

Anika Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

6.85%40.52M

6.67%166.66M

8.45%42.97M

2.98%41.47M

11.71%44.3M

3.35%37.92M

5.71%156.24M

10.61%39.62M

1.84%40.26M

3.96%39.66M

Operating revenue

6.85%40.52M

6.67%166.66M

8.45%42.97M

2.98%41.47M

11.71%44.3M

3.35%37.92M

5.71%156.24M

10.61%39.62M

1.84%40.26M

3.96%39.66M

Cost of revenue

5.40%15.9M

1.46%63.57M

7.43%16.64M

-5.51%16.52M

3.62%15.33M

1.29%15.08M

-3.38%62.66M

-12.42%15.49M

5.89%17.49M

-14.64%14.8M

Gross profit

7.81%24.63M

10.16%103.09M

9.11%26.33M

9.50%24.94M

16.53%28.97M

4.77%22.84M

12.82%93.58M

33.07%24.13M

-1.06%22.78M

19.46%24.86M

Operating expense

-16.12%29.69M

13.77%128.54M

-9.34%27.92M

14.14%32.62M

15.44%32.6M

39.59%35.4M

11.39%112.98M

16.52%30.8M

13.52%28.58M

11.71%28.24M

Selling and administrative expenses

-20.26%21.53M

13.04%95.85M

-11.77%20.34M

16.69%24.83M

11.38%23.69M

40.60%27M

14.44%84.79M

12.81%23.05M

21.58%21.28M

18.23%21.27M

Research and development costs

-2.81%8.16M

16.00%32.69M

-2.12%7.59M

6.71%7.79M

27.80%8.91M

36.43%8.4M

3.13%28.18M

29.15%7.75M

-4.85%7.3M

-4.36%6.98M

Operating profit

59.67%-5.06M

-31.18%-25.45M

76.14%-1.59M

-32.36%-7.67M

-7.39%-3.63M

-253.21%-12.55M

-4.98%-19.4M

19.66%-6.67M

-169.67%-5.8M

24.36%-3.38M

Net non-operating interest income expense

9.83%592K

253.52%2.31M

109.06%577K

45.64%635K

484.38%561K

450.00%539K

447.87%654K

687.23%276K

1,008.33%436K

292.00%96K

Total other finance cost

-9.83%-592K

-253.52%-2.31M

-109.06%-577K

-45.64%-635K

-484.38%-561K

-450.00%-539K

-447.87%-654K

-687.23%-276K

-1,008.33%-436K

-292.00%-96K

Other net income (expense)

-62.19M

Special income (charges)

----

---62.19M

----

--0

----

-Less：Restructuring and merger&acquisition

----

--0

----

--0

----

-Less:Impairment of capital assets

----

--62.19M

----

--0

----

Income before tax

62.79%-4.47M

-355.17%-85.33M

-888.95%-63.2M

-31.28%-7.04M

6.54%-3.07M

-224.00%-12.01M

-872.39%-18.75M

30.31%-6.39M

-528.27%-5.36M

-135.98%-3.29M

Income tax

102.58%43K

31.57%-2.66M

86.24%-204K

60.99%-463K

25.57%-329K

-114.71%-1.66M

-127.71%-3.89M

56.09%-1.48M

-271.04%-1.19M

-117.01%-442K

Net income

56.39%-4.51M

-456.34%-82.67M

-1,183.62%-63M

-57.51%-6.58M

3.59%-2.74M

-252.88%-10.35M

-459.43%-14.86M

15.28%-4.91M

-848.21%-4.18M

-143.53%-2.84M

Net income continuous Operations

56.39%-4.51M

-456.34%-82.67M

-1,183.62%-63M

-57.51%-6.58M

3.59%-2.74M

-252.88%-10.35M

-459.43%-14.86M

15.28%-4.91M

-848.21%-4.18M

-143.53%-2.84M

Minority interest income

Net income attributable to the parent company

56.39%-4.51M

-456.34%-82.67M

-1,183.62%-63M

-57.51%-6.58M

3.59%-2.74M

-252.88%-10.35M

-459.43%-14.86M

15.28%-4.91M

-848.21%-4.18M

-143.53%-2.84M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

56.39%-4.51M

-456.34%-82.67M

-1,183.62%-63M

-57.51%-6.58M

3.59%-2.74M

-252.88%-10.35M

-459.43%-14.86M

15.28%-4.91M

-848.21%-4.18M

-143.53%-2.84M

Basic earnings per share

56.34%-0.31

-452.94%-5.64

-1,164.71%-4.3

-55.17%-0.45

5.00%-0.19

-255.00%-0.71

-451.72%-1.02

15.00%-0.34

-825.00%-0.29

-144.44%-0.2

Diluted earnings per share

56.34%-0.31

-452.94%-5.64

-1,164.71%-4.3

-55.17%-0.45

5.00%-0.19

-255.00%-0.71

-464.29%-1.02

15.00%-0.34

-825.00%-0.29

-144.44%-0.2

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	6.85%40.52M	6.67%166.66M	8.45%42.97M	2.98%41.47M	11.71%44.3M	3.35%37.92M	5.71%156.24M	10.61%39.62M	1.84%40.26M	3.96%39.66M
Operating revenue	6.85%40.52M	6.67%166.66M	8.45%42.97M	2.98%41.47M	11.71%44.3M	3.35%37.92M	5.71%156.24M	10.61%39.62M	1.84%40.26M	3.96%39.66M
Cost of revenue	5.40%15.9M	1.46%63.57M	7.43%16.64M	-5.51%16.52M	3.62%15.33M	1.29%15.08M	-3.38%62.66M	-12.42%15.49M	5.89%17.49M	-14.64%14.8M
Gross profit	7.81%24.63M	10.16%103.09M	9.11%26.33M	9.50%24.94M	16.53%28.97M	4.77%22.84M	12.82%93.58M	33.07%24.13M	-1.06%22.78M	19.46%24.86M
Operating expense	-16.12%29.69M	13.77%128.54M	-9.34%27.92M	14.14%32.62M	15.44%32.6M	39.59%35.4M	11.39%112.98M	16.52%30.8M	13.52%28.58M	11.71%28.24M
Selling and administrative expenses	-20.26%21.53M	13.04%95.85M	-11.77%20.34M	16.69%24.83M	11.38%23.69M	40.60%27M	14.44%84.79M	12.81%23.05M	21.58%21.28M	18.23%21.27M
Research and development costs	-2.81%8.16M	16.00%32.69M	-2.12%7.59M	6.71%7.79M	27.80%8.91M	36.43%8.4M	3.13%28.18M	29.15%7.75M	-4.85%7.3M	-4.36%6.98M
Operating profit	59.67%-5.06M	-31.18%-25.45M	76.14%-1.59M	-32.36%-7.67M	-7.39%-3.63M	-253.21%-12.55M	-4.98%-19.4M	19.66%-6.67M	-169.67%-5.8M	24.36%-3.38M
Net non-operating interest income expense	9.83%592K	253.52%2.31M	109.06%577K	45.64%635K	484.38%561K	450.00%539K	447.87%654K	687.23%276K	1,008.33%436K	292.00%96K
Total other finance cost	-9.83%-592K	-253.52%-2.31M	-109.06%-577K	-45.64%-635K	-484.38%-561K	-450.00%-539K	-447.87%-654K	-687.23%-276K	-1,008.33%-436K	-292.00%-96K
Other net income (expense)		-62.19M
Special income (charges)	----	---62.19M	----	----	----	----	--0	----	----	----
-Less：Restructuring and merger&acquisition	----	--0	----	----	----	----	--0	----	----	----
-Less:Impairment of capital assets	----	--62.19M	----	----	----	----	--0	----	----	----
Income before tax	62.79%-4.47M	-355.17%-85.33M	-888.95%-63.2M	-31.28%-7.04M	6.54%-3.07M	-224.00%-12.01M	-872.39%-18.75M	30.31%-6.39M	-528.27%-5.36M	-135.98%-3.29M
Income tax	102.58%43K	31.57%-2.66M	86.24%-204K	60.99%-463K	25.57%-329K	-114.71%-1.66M	-127.71%-3.89M	56.09%-1.48M	-271.04%-1.19M	-117.01%-442K
Net income	56.39%-4.51M	-456.34%-82.67M	-1,183.62%-63M	-57.51%-6.58M	3.59%-2.74M	-252.88%-10.35M	-459.43%-14.86M	15.28%-4.91M	-848.21%-4.18M	-143.53%-2.84M
Net income continuous Operations	56.39%-4.51M	-456.34%-82.67M	-1,183.62%-63M	-57.51%-6.58M	3.59%-2.74M	-252.88%-10.35M	-459.43%-14.86M	15.28%-4.91M	-848.21%-4.18M	-143.53%-2.84M
Minority interest income
Net income attributable to the parent company	56.39%-4.51M	-456.34%-82.67M	-1,183.62%-63M	-57.51%-6.58M	3.59%-2.74M	-252.88%-10.35M	-459.43%-14.86M	15.28%-4.91M	-848.21%-4.18M	-143.53%-2.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	56.39%-4.51M	-456.34%-82.67M	-1,183.62%-63M	-57.51%-6.58M	3.59%-2.74M	-252.88%-10.35M	-459.43%-14.86M	15.28%-4.91M	-848.21%-4.18M	-143.53%-2.84M
Basic earnings per share	56.34%-0.31	-452.94%-5.64	-1,164.71%-4.3	-55.17%-0.45	5.00%-0.19	-255.00%-0.71	-451.72%-1.02	15.00%-0.34	-825.00%-0.29	-144.44%-0.2
Diluted earnings per share	56.34%-0.31	-452.94%-5.64	-1,164.71%-4.3	-55.17%-0.45	5.00%-0.19	-255.00%-0.71	-464.29%-1.02	15.00%-0.34	-825.00%-0.29	-144.44%-0.2
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall